sutures newsletter

PRODUCED BY AND FOR MEMBERS OF THE DEPARTMENT OF SURGERY October 2015 | Archived Issues

FDA Requires Drug Interaction Studies for Kayexalate

Pharmacy Focus

The U.S. Food and Drug Administration is requiring the manufacturer of the hyperkalemia drug Kayexalate to conduct studies to investigate Kayexalate's potential to bind to other medications administered by mouth — drug interactions that could affect how well the other medications work.


Mark Your Calendar


Surgery Grand Rounds

Click the "read more" to see information about upcoming Surgery Grand Rounds.


Grand Rounds

Click here to view a schedule of all upcoming grand rounds.


Education Schedule

Click the PDF links below to see the Department of Surgery's education schedule.

Education Schedule - October 2015 (PDF)

Education Schedule - November 2015 (PDF)  


Surgery Scheduling

Click the "read more" for hours and contact information for surgery scheduling.

Share Your News

Know an interesting colleague we should profile? A story we should tell? Submit your ideas, meetings and events for consideration.

Click here to submit your news to Sutures

Transplant Trailblazer Named 'Pioneer'

Pioneer in Medicine 2015

"It's really a privilege to be a physician and a scientist," said Stanley C. Jordan, MD, winner of the 2015 Pioneer in Medicine Award.

Jordan's Decision to Pursue Medicine Has Helped Many Who Need New Kidneys

Stanley C. Jordan, MD, decided to pursue medicine shortly after his diagnosis with polio. He was 5.

The impetus behind his decision was simple. A healthcare provider comforted Jordan when no one else really could, and this individual's efforts left such a lasting impression on the 5-year-old from Sparta, North Carolina, that medicine became his career of choice.

Jordan received the prestigious Pioneer in Medicine Award during the annual meeting of the medical staff Oct. 19.

Even after all these years, Jordan hasn't forgotten the comforting clinician. "I felt his compassion and understanding that what I needed was to be comforted," Jordan said during a video tribute in his honor at the meeting. "Never underestimate the power of interactions you have with others."

Jordan's decision to pursue medicine has led to highly sensitized patients worldwide receiving kidney transplants, and the Kidney Transplant Program at the Cedars-Sinai Comprehensive Transplant Center has become an international referral center for patients with high immunological risk.

Vice Chief of Staff Peggy Miles, MD, and Cynthia Nast, MD, professor of Pathology at Cedars-Sinai, introduced and presented the award to Jordan.

"Dr. Jordan is an exceptional clinician and educator who has inspired trainees and colleagues, giving hope to patients in need of kidney transplants around the world," Nast said.

Jordan, director of Nephrology and Transplant Immunology and medical director of the Kidney Transplant Program, has made paradigm-shifting discoveries in the fields of immunology and kidney transplants. He and his team pioneered the use of intravenous immunoglobulin to reduce the risk of rejection in difficult cases in which other medications have failed. He also created a technique to detect post-transplant lymphoproliferative disorder in its earliest stages.

In his research, Jordan continues to pursue desensitization protocols for highly HLA-sensitized patients.

Among those in the audience Oct. 19, were Jordan's wife, Susan, two of his daughters and his two grandchildren, seated with him at a table in front.

Jordan was welcomed to the podium with a standing ovation. He thanked a long list of people, including his family, his team and others at Cedars-Sinai.

"I couldn't have asked for a better life," said Jordan, who started at Cedars-Sinai in 1986.

Throughout his acceptance speech, Jordan never wavered from what has brought him this far — his devotion to comforting those in need.

"It's really a privilege to be a physician and a scientist. Medicine has changed a lot over the years, and too often we get lost in computers and algorithms," he said. "It is important we maintain compassion and the human touch."

This is Jordan's second major Cedars-Sinai award this year. In June, he received the inaugural PRISM research prize for his major contributions to the treatment and care of organ transplant patients.